Kamada Ltd. (TLV:KMDA)
2,243.00
-21.00 (-0.93%)
At close: Dec 25, 2025
Kamada Market Cap
Kamada has a market cap or net worth of 1.29 billion as of December 26, 2025. Its market cap has increased by 4.57% in one year.
Market Cap
1.29B
Enterprise Value
1.09B
Revenue
578.74M
Ranking
n/a
PE Ratio
19.38
Stock Price
2,243.00
Market Cap Chart
Since September 12, 2005, Kamada's market cap has increased from 84.35M to 1.29B, an increase of 1,433.83%. That is a compound annual growth rate of 14.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 25, 2025 | 1.29B | 1.78% |
| Dec 31, 2024 | 1.27B | -0.69% |
| Dec 31, 2023 | 1.28B | 108.12% |
| Dec 29, 2022 | 615.02M | -33.18% |
| Dec 30, 2021 | 920.36M | -0.46% |
| Dec 31, 2020 | 924.59M | -3.70% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 116.00B |
| Danel (Adir Yeoshua) | 2.83B |
| BrainsWay | 1.22B |
| SofWave Medical | 1.03B |
| Bait Bakfar | 1.00B |
| Ilex Medical | 745.91M |
| Novolog (Pharm-Up 1966) | 666.18M |
| Bonus BioGroup | 273.29M |